array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Tue, 03 Dec 2024 00:15:09 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IjhlODBYNzM3Uk5HYnh5VzM4YzcyMkE9PSIsInZhbHVlIjoiamlMQzQ5ZVpRWjNyM081VEFabitqaGRnV3lxNUM1RllwSHkyNDBFN0tvd3NsMzlEZkNJZ0JwNnFGWnZZcy9ySHE5U3U5cFNvZGRKaERUdG8xaGYwNUpQY0h3WjF1Wk5NNDlDSHhQbDhUMUZ5MG5VMTlhWmVDZWxBbDFzUjlQZ1AiLCJtYWMiOiIxNDc5OTI3OTU3Zjg4ZTAyMjNlODljODYwOWRlNDc1NzhiZGIzMWE0NjQ2NWYyZTRhYmQ1OTU4ODFkMWMzNzBiIiwidGFnIjoiIn0%3D; expires=Thu, 05 Dec 2024 12:15:09 GMT; Max-Age=216000; path=/; secure; samesite=strict"
    1 => "eurekaselectnew_session=eyJpdiI6ImV0aS8vcEVxUHVzQmxLZnRzVjJqa3c9PSIsInZhbHVlIjoiMVVWWGw5T08rcDdoTUNEYTROdkRRMHR4K3hTektzWE9qU1E1cU9aK1FPNGFSejRaT1l1WDBoMEp6SDZaRTR6emdPT0gzeGs2Um9INEFCYUFsRFNzanJhUFRkRTMrN2xoNkgrRERNcEU2aVkxRUlIMXJBZmYwNlQ1MUlqLy9aRkciLCJtYWMiOiJjZDg3YmNiYTFkMGVhMWFjMjAwODY2NWM4ZGU5YTlhMDQwZTAxZDJjNGE2MTU4MjBiOTcyYmMwZTM0NzU0YTE3IiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=strict"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IjhlODBYNzM3Uk5HYnh5VzM4YzcyMkE9PSIsInZhbHVlIjoiamlMQzQ5ZVpRWjNyM081VEFabitqaGRnV3lxNUM1RllwSHkyNDBFN0tvd3NsMzlEZkNJZ0JwNnFGWnZZcy9ySHE5U3U5cFNvZGRKaERUdG8xaGYwNUpQY0h3WjF1Wk5NNDlDSHhQbDhUMUZ5MG5VMTlhWmVDZWxBbDFzUjlQZ1AiLCJtYWMiOiIxNDc5OTI3OTU3Zjg4ZTAyMjNlODljODYwOWRlNDc1NzhiZGIzMWE0NjQ2NWYyZTRhYmQ1OTU4ODFkMWMzNzBiIiwidGFnIjoiIn0%3D; expires=Thu, 05-Dec-2024 12:15:09 GMT; path=/; secure"
    1 => "eurekaselectnew_session=eyJpdiI6ImV0aS8vcEVxUHVzQmxLZnRzVjJqa3c9PSIsInZhbHVlIjoiMVVWWGw5T08rcDdoTUNEYTROdkRRMHR4K3hTektzWE9qU1E1cU9aK1FPNGFSejRaT1l1WDBoMEp6SDZaRTR6emdPT0gzeGs2Um9INEFCYUFsRFNzanJhUFRkRTMrN2xoNkgrRERNcEU2aVkxRUlIMXJBZmYwNlQ1MUlqLy9aRkciLCJtYWMiOiJjZDg3YmNiYTFkMGVhMWFjMjAwODY2NWM4ZGU5YTlhMDQwZTAxZDJjNGE2MTU4MjBiOTcyYmMwZTM0NzU0YTE3IiwidGFnIjoiIn0%3D; path=/; secure; httponly"
  ]
]
Search Result "Andexanet alfa PER977 (ciraparantag)"

Specific Antidotes in Development for Reversal of Novel Anticoagulants: A Review

Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs)

Apply Filters

Content Type
